
Kalaris Therapeutics Inc
KLRSHealthcare|Biotechnology|US
$2.42
+0.06 (+2.54%)
DCF Value
$6.25
Tangible Book / Share
$2.42
Cash / Share
$3.93
Ownership Breakdown
36.3%
Float
23.8M
Shares Outstanding
8.6M
Float Shares
Major Holders (8)
Combined: 31.7%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Coastlands Capital LLC | HC, OO | 5.69% | 1,355,119 | Oct 26, 2026 | 13D/G |
| Coastlands Capital Partners LP | Partnership | 5.69% | 1,355,119 | Oct 26, 2026 | 13D/G |
| Coastlands Capital GP LLC | Other | 5.69% | 1,355,119 | Oct 26, 2026 | 13D/G |
| Matthew D. Perry | HC, IN | 5.69% | 1,355,119 | Oct 26, 2026 | 13D/G |
| Coastlands Capital LP | IA, PN | 5.69% | 1,355,119 | Oct 26, 2026 | 13D/G |
| Oleg Nodelman | HC, IN | 1.10% | 201,718 | May 15, 2025 | 13D/G |
| EcoR1 Capital, LLC | IA, OO | 1.10% | 201,718 | May 15, 2025 | 13D/G |
| EcoR1 Capital Fund Qualified, L.P. | Partnership | 1.00% | 191,242 | May 15, 2025 | 13D/G |
Insider Trades (59)
Last 4 quarters: 3,302,355 acquired · 68,821 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Vandekop Amy O'Leary | VP, Corporate Controller | Aug 27, 2026 | AWARD | 10,000 | $4.10 | $41.0K | Form 4 |
| KEATING LAURIE | director | Aug 1, 2026 | AWARD | 18,000 | $3.51 | $63.2K | Form 4 |
| KEATING LAURIE | Aug 1, 2026 | OTHER | 0 | — | — | Form 4 | |
| Vandekop Amy O'Leary | See Remarks | Jul 27, 2026 | OTHER | 0 | — | — | Form 4 |
| Vandekop Amy O'Leary | See Remarks | Jul 27, 2026 | OTHER | 27,415 | $7.31 | $200.4K | Form 4 |
| Vandekop Amy O'Leary | See Remarks | Jul 27, 2026 | OTHER | 20,000 | $6.81 | $136.2K | Form 4 |
| Bayko Liisa Ann | Chief Financial Officer | Jul 20, 2026 | AWARD | 220,000 | $4.00 | $880.0K | Form 4 |
| Bayko Liisa Ann | Jul 20, 2026 | OTHER | 0 | — | — | Form 4 | |
| Jovan-Embiricos Morana | director | Jun 3, 2026 | AWARD | 9,000 | $4.72 | $42.5K | Form 4 |
| Ferrara Napoleone | director | Jun 3, 2026 | AWARD | 9,000 | $4.72 | $42.5K | Form 4 |
| Hallal David | director | Jun 3, 2026 | AWARD | 9,000 | $4.72 | $42.5K | Form 4 |
| AKKARAJU SRINIVAS | director | Jun 3, 2026 | AWARD | 9,000 | $4.72 | $42.5K | Form 4 |
| Dybbs Michael | director | Jun 3, 2026 | AWARD | 9,000 | $4.72 | $42.5K | Form 4 |
| ADAMIS ANTHONY P | director | Jun 3, 2026 | AWARD | 9,000 | $4.72 | $42.5K | Form 4 |
| PATTERSON LEONE D | director | Jun 3, 2026 | AWARD | 9,000 | $4.72 | $42.5K | Form 4 |
| AKKARAJU SRINIVAS | director, 10 percent owner: | May 20, 2026 | DISPOSED | 66,906 | — | — | Form 4 |
| AKKARAJU SRINIVAS | director, 10 percent owner: | May 20, 2026 | BUY | 244,300 | $4.83 | $1.2M | Form 4 |
| AKKARAJU SRINIVAS | director, 10 percent owner: | May 20, 2026 | J | 4,471 | — | — | Form 4 |
| AKKARAJU SRINIVAS | director, 10 percent owner: | May 20, 2026 | J | 14,937 | — | — | Form 4 |
| Hagen Brett R | Chief Accounting Officer | Mar 19, 2026 | AWARD | 60,800 | $6.81 | $414.0K | Form 4 |
| Hagen Brett R | Chief Accounting Officer | Mar 20, 2026 | SELL | 1,915 | $6.72 | $12.9K | Form 4 |
| Oxtoby Andrew | director, officer: See Remarks | Mar 19, 2026 | AWARD | 222,000 | $6.81 | $1.5M | Form 4 |
| Gall Matthew | Chief Financial Officer | Mar 19, 2026 | AWARD | 95,000 | $6.81 | $647.0K | Form 4 |
| Feinsod Matthew | Chief Medical Officer | Mar 19, 2026 | AWARD | 135,000 | $6.81 | $919.4K | Form 4 |
| AKKARAJU SRINIVAS | director, 10 percent owner: | Dec 18, 2025 | BUY | 479,847 | $10.42 | $5.0M | Form 4 |
| AKKARAJU SRINIVAS | director, 10 percent owner: | Dec 22, 2025 | AWARD | 1,500,000 | $10.00 | $15.0M | Form 4 |
| Gall Matthew | Chief Financial Officer | Nov 3, 2025 | AWARD | 235,000 | $4.99 | $1.2M | Form 4 |
| Gall Matthew | Nov 3, 2025 | OTHER | 0 | — | — | Form 4 | |
| Hagen Brett R | Chief Accounting Officer | Apr 10, 2025 | AWARD | 50,262 | $7.31 | $367.4K | Form 4 |
| AKKARAJU SRINIVAS | director, 10 percent owner: | Apr 10, 2025 | AWARD | 18,000 | $7.31 | $131.6K | Form 4 |
| Jovan-Embiricos Morana | director | Apr 10, 2025 | AWARD | 18,000 | $7.31 | $131.6K | Form 4 |
| PATEL SAMIR CHANDRAKANT | director | Apr 10, 2025 | AWARD | 18,000 | $7.31 | $131.6K | Form 4 |
| Ferrara Napoleone | director | Apr 10, 2025 | AWARD | 18,000 | $7.31 | $131.6K | Form 4 |
| Oxtoby Andrew | director, officer: See Remarks | Apr 10, 2025 | AWARD | 287,000 | $7.31 | $2.1M | Form 4 |
| ADAMIS ANTHONY P | director | Apr 10, 2025 | AWARD | 18,000 | $7.31 | $131.6K | Form 4 |
| Feinsod Matthew | Chief Medical Officer | Apr 10, 2025 | AWARD | 101,000 | $7.31 | $738.3K | Form 4 |
| Feinsod Matthew | Chief Medical Officer | Apr 10, 2025 | AWARD | 70,551 | $7.31 | $515.7K | Form 4 |
| PATTERSON LEONE D | director | Apr 10, 2025 | AWARD | 18,000 | $7.31 | $131.6K | Form 4 |
| PATTERSON LEONE D | Apr 3, 2025 | OTHER | 0 | — | — | Form 4 | |
| Hagen Brett R | Chief Accounting Officer | Mar 26, 2025 | SELL | 907 | $8.97 | $8.1K | Form 4 |
| AKKARAJU SRINIVAS | director, 10 percent owner: | Mar 18, 2025 | OTHER | 0 | — | — | Form 4 |
| Samsara BioCapital GP, LLC | 10 percent owner | Mar 18, 2025 | OTHER | 0 | — | — | Form 4 |
| Ferrara Napoleone | director | Mar 18, 2025 | AWARD | 504,000 | — | — | Form 4 |
| PATEL SAMIR CHANDRAKANT | director | Mar 18, 2025 | AWARD | 252,000 | — | — | Form 4 |
| PATEL SAMIR CHANDRAKANT | director | Mar 18, 2025 | AWARD | 105,913 | $0.85 | $90.0K | Form 4 |
| PATEL SAMIR CHANDRAKANT | director | Mar 18, 2025 | AWARD | 100,800 | — | — | Form 4 |
| Feinsod Matthew | Chief Medical Officer | Mar 18, 2025 | AWARD | 28,224 | $0.85 | $24.0K | Form 4 |
| Feinsod Matthew | Chief Medical Officer | Mar 18, 2025 | AWARD | 4,030 | — | — | Form 4 |
| Oxtoby Andrew | director, officer: See Remarks | Mar 18, 2025 | AWARD | 476,611 | $0.85 | $405.1K | Form 4 |
| AKKARAJU SRINIVAS | director, 10 percent owner: | Mar 18, 2025 | AWARD | 11,444,503 | — | — | Form 4 |
| ADAMIS ANTHONY P | director | Mar 18, 2025 | AWARD | 19,484 | $0.55 | $10.7K | Form 4 |
| ADAMIS ANTHONY P | director | Mar 18, 2025 | AWARD | 12,989 | $0.55 | $7.1K | Form 4 |
| AKKARAJU SRINIVAS | Mar 18, 2025 | OTHER | 0 | — | — | Form 4 | |
| Ferrara Napoleone | Mar 18, 2025 | OTHER | 0 | — | — | Form 4 | |
| Dybbs Michael | Mar 18, 2025 | OTHER | 0 | — | — | Form 4 | |
| PATEL SAMIR CHANDRAKANT | Mar 18, 2025 | OTHER | 0 | — | — | Form 4 | |
| Oxtoby Andrew | Mar 18, 2025 | OTHER | 0 | — | — | Form 4 | |
| Feinsod Matthew | Mar 18, 2025 | OTHER | 0 | — | — | Form 4 | |
| ADAMIS ANTHONY P | Mar 18, 2025 | OTHER | 0 | — | — | Form 4 |